2018
DOI: 10.1161/strokeaha.117.019341
|View full text |Cite
|
Sign up to set email alerts
|

Predictors of Thrombolysis Administration in Mild Stroke

Abstract: Mild acutely presenting stroke patients are more likely to receive thrombolysis if they are young, white, or Hispanic and arrive early to the hospital with more severe neurological presentation. Identification of predictors of thrombolysis is important in design of future studies to assess the use of thrombolysis for mild stroke.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
9
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 29 publications
(9 citation statements)
references
References 25 publications
(17 reference statements)
0
9
0
Order By: Relevance
“…8 Additionally, prior observational cohorts not undergoing thrombolysis may have included more severely affected patients, given recent trends toward increased use of alteplase for patients with minor stroke in clinical practice. 4,5 An increase in sICH was associated with alteplase in this population (risk difference, 3.3%; 95% CI, 0.8%-7.4%) without an associated increase in mortality. In a nationwide US registry, among 5910 patients with NIHSS scores of 0 to 5 treated with alteplase in routine practice, a 1.8% (95% CI, 1.5%-2.2%) absolute risk of sICH was observed.…”
Section: Discussionmentioning
confidence: 81%
See 1 more Smart Citation
“…8 Additionally, prior observational cohorts not undergoing thrombolysis may have included more severely affected patients, given recent trends toward increased use of alteplase for patients with minor stroke in clinical practice. 4,5 An increase in sICH was associated with alteplase in this population (risk difference, 3.3%; 95% CI, 0.8%-7.4%) without an associated increase in mortality. In a nationwide US registry, among 5910 patients with NIHSS scores of 0 to 5 treated with alteplase in routine practice, a 1.8% (95% CI, 1.5%-2.2%) absolute risk of sICH was observed.…”
Section: Discussionmentioning
confidence: 81%
“…Clinical use of alteplase for ischemic stroke with low National Institutes of Health Stroke Scale (NIHSS) scores has increased in recent years, presumably based on concern for this substantial poststroke disability. 4,5 Although alteplase is the standard of care for patients with ischemic stroke and disabling deficits regardless of severity judged by NIHSS scores, 6,7 the optimal management of patients with not clearly disabling deficits is unclear. Most major trials of alteplase (NINDS Parts 1 and 2; ECASS 1, 2, and 3; Atlantis Parts A and B; and EPITHET) explicitly excluded varying subsets of patients with the mildest deficits (see eTable 1 in Supplement 1 for exclusion criteria).…”
mentioning
confidence: 99%
“…The physicians' fears of risk of intracranial hemorrhage among other side effects of thrombolytic therapy may play a role in clinical decision to treat patients which affects the DTN [37]. Khathami et al [38] claimed that the main reasons for emergency physicians who do not recommend tPA use were that they found the said treatment lacking efficacy or effectiveness.…”
Section: Barriers On Timely Administration Of Tpamentioning
confidence: 99%
“…The 2019 guidelines for AIS thus recommended that minor disabling AIS patients could be treated with alteplase [ 5 ]. Treatment with alteplase in minor stroke has increased in recent years to reduce potential post-stroke disability [ 6 , 7 ].…”
Section: Introductionmentioning
confidence: 99%